Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Chronic Disease|November 29, 2023
Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meetingXuejiao Yin, Yi Liu, Jianai Sun, et al.
Hematology (Amsterdam, Netherlands)|June 23, 2020
The diagnostic and prognostic value of MRI in central nervous system involvement of acute myeloid leukemia: a retrospective cohort of 84 patientsHuafei Shen, Yanchun Zhao, Yuanfei Shi, et al.
British Journal of Cancer|May 28, 2024
PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic syndromesFangliang Zhang, Jianai Sun, Lei Zhang, et al.
Cancer Medicine|October 6, 2022
The efficacy and cardiac toxicity of different-dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphomaLi Li, Rongrong Chen, De Zhou, et al.
Annals of Hematology|August 21, 2017
Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemiaYinjun Lou, Yafang Ma, Jianai Sun, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 22, 2019
Factors Affecting Early Death and Survival of Patients With Acute Promyelocytic Leukemia Treated With ATRA-Based Therapy RegimensJianai Sun, Jingjing Zhu, De Zhou, et al.
Annals of Hematology|August 22, 2015
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patientsYinjun Lou, Yafang Ma, Jianai Sun, et al.
European Journal of Medical Research|January 8, 2026
Global, regional, and national burden of lymphoma from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 1990-2021Yuanfei Shi, Tianle Cao, Yi Xu, et al.
Plos One|October 6, 2016
HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 ParticipantsMixue Xie, Qi Jiang, Li Li, et al.
Hematology (Amsterdam, Netherlands)|April 12, 2022
The favorable prognostic value of the loss of sex chromosomes in patients with t(8;21) acute myeloid leukemia: an exploratory studyLixia Zhu, Rongrong Chen, Xueying Li, et al.
Pageof 2